5:09 PM ET
8-K
M&A Deal
BIO-TECHNE M&A Deal with Merck KGaA, Darmstadt, Germany
Bio-Techne shareholders voted to approve the company's acquisition by Merck KGaA, Darmstadt, Germany, at a special meeting held on September 23, 2026. The transaction has also cleared the HSR Act antitrust waiting period and is expected to close by late 2026 or early 2027. Bio-Techne will become a wholly-owned subsidiary of Merck KGaA upon completion of the merger.
- Counterparty
- Merck KGaA, Darmstadt, Germany